“Modulation of Glycemic, Lipid, and HepatorenalBiomarkers by Silymarin Supplementation InType 2 Diabetes Mellitus”. The Review of Diabetic Studies , vol. 21, no. 1, May 2025, https://doi.org/10.1900/1z2dn188.